Hoffmann-La Roche Limited
Registration:
22
of
37
(2020-11-04
to
2020-12-08)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Discuss the Canadian Personalized Healthcare Innovation Network (CPHIN) and the potential impacts and partnering opportunities for this project in the province of British Columbia, and in Canada.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals
|
To actively promote the contributions and positive impact of pharmaceutical innovation and the innovative pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system. Ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals. Work with the Ministry of Health regarding public reimbursement of our innovative pharmaceutical products.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals
|